Integrative bioinformatics and machine learning approaches identify novel diagnostic signatures for oxaliplatin-resistant colorectal cancer

Key Points

• This research aims to identify a multi-gene diagnostic signature associated with oxaliplatin resistance in colorectal cancer.
• Integrative bioinformatics analysis to characterize molecular features.
• Machine learning techniques to develop the diagnostic signature.
• Identification of potential therapeutic targets based on resistance mechanisms.
• Developed a novel multi-gene signature for predicting oxaliplatin resistance.
• Provided insights into underlying resistance mechanisms.
• Identified potential therapeutic candidates for improved clinical management.